Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to set up the larger prospective study on robotic partial nephrectomy, to describe the characteristics of patients operated for kidney cancer by this surgical procedure and also to determine the modalities of hemostasis in this procedure.
The primary objective of the study is to describe the characteristics of patients operated for kidney cancer by a robotic partial nephrectomy in France (recruiting centers, patient profile, tumor characteristics).
Secondary Objective(s):
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients | Robotic partial surgery |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Robotic partial surgery | Procedure | Robotic partial surgery |
|
| Measure | Description | Time Frame |
|---|---|---|
| Post-operative complications evaluated according to the Clavien criteria | Per and post-operative transfusion rates | From surgery until 1 year of follow up |
| Post-operative complications evaluated according to the Clavien criteria | Medical or surgical complication rates | From surgery until 1 year of follow up |
| Post-operative complications evaluated according to the Clavien criteria | Clavien's grading | From surgery until 1 year of follow up |
| Post-operative complications evaluated according to the Clavien criteria | Urinary fistula rate | From surgery until 1 year of follow up |
| Post-operative complications evaluated according to the Clavien criteria | Necessity for nephrectomy or re-exploration | From surgery until 1 year of follow up |
| Post-operative complications evaluated according to the Clavien criteria | Length of hospital stay | From surgery until 1 year of follow up |
| Measure | Description | Time Frame |
|---|---|---|
| Renal function after robotic partial nephrectomy measured by biological parameters | Creatininemia | Follow-up during 12 months |
| Renal function after robotic partial nephrectomy measured by biological parameters |
Not provided
Inclusion Criteria:
Exclusion Criteria: None
Not provided
Not provided
Not provided
Patients operated for kidney cancer by this surgical procedure
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jean-Christophe BERNHARD, PHU | University Hospital, Bordeaux | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Bordeaux | Bordeaux | 33076 | France | |||
| CHU Grenoble |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37407720 | Derived | Margue G, Ingels A, Bensalah K, Doumerc N, Vaessen C, Roupret M, Audenet F, Mejean A, Bruyere F, Olivier J, Baumert H, Michel C, Paparel P, Parier B, Sebe P, Long JA, Lang H, Lebret T, Patard JJ, Bernhard JC. Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French Kidney Cancer Research Network (UroCCR 10). World J Urol. 2023 Aug;41(8):2281-2288. doi: 10.1007/s00345-023-04491-z. Epub 2023 Jul 6. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007680 | Kidney Neoplasms |
| ID | Term |
|---|---|
| D014571 | Urologic Neoplasms |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
MDRD GFR
| Follow-up during 12 months |
| Per-operative modalities of haemostasis procedure | Haemostasis procedure | At Surgery |
| Per-operative modalities of haemostatic agent | Haemostatic agent | At Surgery |
| La Tronche |
| 38700 |
| France |
| CHRU Lille | Lille | 59000 | France |
| CHU Limoges | Limoges | 87000 | France |
| HCL Lyon | Lyon | 69002 | France |
| CH Diaconesses | Paris | 75012 | France |
| CHU La Pitié Salpétrière/ Kremlin Bicêtre | Paris | 75013 | France |
| CH Saint Joseph | Paris | 75014 | France |
| Hôpital Européen Georges Pompidou | Paris | 75015 | France |
| CHU Henri MONDOR | Paris | 94010 | France |
| CHU Rennes - Centre Eugène Marquis | Rennes | 35000 | France |
| CHU Strasbourg | Strasbourg | 67000 | France |
| CH Foch | Suresnes | 92151 | France |
| CHU Toulouse - Centre Claudius Régaud | Toulouse | 31059 | France |
| CHU Tours | Tours | 37000 | France |
| D052776 |
| Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052801 | Male Urogenital Diseases |